Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management

    July 2002 in “ The Neurologist ”
    Elliot M. Frohman, Ted Phillips, Kristen Kokel, Jerry Van Pelt, Shirley O’Leary, Shelly Gross, Kathleen Hawker, Michael K. Racke
    Image of study
    TLDR A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.
    The document from 2002 provides a comprehensive overview of strategies for managing side effects and optimizing treatment compliance for multiple sclerosis (MS) patients using disease-modifying agents (DMAs) such as interferon beta-1a, interferon beta-1b, and glatiramer acetate. The authors, with experience from approximately 5000 MS patients, emphasize the importance of patient education, managing expectations, and regular compliance assessments. They offer practical advice for managing skin reactions, flu-like symptoms, spasticity, bladder dysfunction, and other side effects like MS-related fatigue, heat sensitivity, and IFN-induced headaches. The document also discusses the management of mood disorders, menstrual abnormalities, pregnancy considerations, and rare adverse events like autoimmune disorders and capillary leak syndrome. It concludes that a comprehensive approach to patient education and side effect management is essential to improve patient adherence and quality of life.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 191 results

      community The mechanism of androgenic alopecia

      in Research/Science  34 upvotes 3 weeks ago
      DHT may inhibit hair growth by affecting mitochondrial function, leading to hair follicle miniaturization. Treatments like minoxidil and PP405 may promote hair growth by altering metabolic pathways, potentially counteracting DHT's effects.

      community Better Than Minoxidil? Topical Sodium Valproate

      in Research/Science  51 upvotes 8 months ago
      Topical sodium valproate may promote hair growth by inhibiting GSK3β, allowing beta-catenin to proliferate, but it has potential side effects and requires more research. The conversation also mentions skepticism about a product called Vdphlo1, which includes sodium valproate and other ingredients.

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 3 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

      community Life Extension - Hair Growth for Men

      in Product  1 upvotes 5 months ago
      A new supplement for hair growth combines black rice, prickly pear, and saw palmetto, showing promising results in increasing hair density and reducing hair loss. The supplement is considered a drug-free alternative to traditional treatments like minoxidil and finasteride.

    Similar Research

    5 / 1000+ results